BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:albuterol (Ventolin) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of albuterol (Ventolin)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07350421-4314@assetmemo.bio
DTSTAMP:20261121T004938Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:albuterol (Ventolin): Phase na readout est. (NCT07350421)
DESCRIPTION:albuterol (Ventolin)\, phase na.\nStudy: The Effectiveness of I
 nhaled Salbutamol in the Management of Transient Tachypnea of the Newborn(
 TTN)\nEstimated primary completion: 1 January 2027. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/albuterol-ventolin#upcoming-events\nRegistr
 y record: https://clinicaltrials.gov/study/NCT07350421
URL:https://assetmemo.bio/drug/albuterol-ventolin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06433921-4314@assetmemo.bio
DTSTAMP:20261121T004938Z
DTSTART;VALUE=DATE:20270416
DTEND;VALUE=DATE:20270417
SUMMARY:albuterol (Ventolin): Phase 1 readout est. (NCT06433921)
DESCRIPTION:albuterol (Ventolin)\, phase 1\, Asthma.\nStudy: A Study to Com
 pare the Relative Potency of Salbutamol Administered Via Metered Dose Inha
 lers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics 
 Aged 18 to 65 Inclusive\nEstimated primary completion: 16 April 2027. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/albuterol-ventolin#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT06433921
URL:https://assetmemo.bio/drug/albuterol-ventolin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT03522831-4314@assetmemo.bio
DTSTAMP:20261121T004938Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:albuterol (Ventolin): Phase na readout est. (NCT03522831)
DESCRIPTION:albuterol (Ventolin)\, phase na.\nStudy: CF Bronchodilation\nEs
 timated primary completion: 31 December 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/albuterol-ventolin#upcoming-events\nRegistry reco
 rd: https://clinicaltrials.gov/study/NCT03522831
URL:https://assetmemo.bio/drug/albuterol-ventolin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07426458-4314@assetmemo.bio
DTSTAMP:20261121T004938Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:albuterol (Ventolin): Phase 4 readout est. (NCT07426458)
DESCRIPTION:albuterol (Ventolin)\, phase 4\, Asthma.\nStudy: Ventilation an
 d Perfusion in Asthmatics\nEstimated primary completion: April 2028. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/albuterol-ventolin#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07426458
URL:https://assetmemo.bio/drug/albuterol-ventolin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07877519-4314@assetmemo.bio
DTSTAMP:20261121T004938Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:albuterol (Ventolin): Phase na readout est. (NCT07877519)
DESCRIPTION:albuterol (Ventolin)\, phase na.\nStudy: Conscious Sedation Ver
 sus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibr
 illation\nEstimated primary completion: June 2028. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/albuterol-ventolin#upcoming-events\nRegistry
  record: https://clinicaltrials.gov/study/NCT07877519
URL:https://assetmemo.bio/drug/albuterol-ventolin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07037511-4314@assetmemo.bio
DTSTAMP:20261121T004938Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:albuterol (Ventolin): Phase na readout est. (NCT07037511)
DESCRIPTION:albuterol (Ventolin)\, phase na\, Asthma.\nStudy: Effects of Sa
 lbutamol in Athletes and Implications for Screening and Sports\nEstimated 
 primary completion: 31 December 2029. This is a ClinicalTrials.gov estimat
 e\, not a confirmed readout date\, and it can move.\nDrug page: https://as
 setmemo.bio/drug/albuterol-ventolin#upcoming-events\nRegistry record: http
 s://clinicaltrials.gov/study/NCT07037511
URL:https://assetmemo.bio/drug/albuterol-ventolin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
